A brand new remedy almost halves the chance of illness development or loss of life from a much less widespread type of breast most cancers that hasn’t seen main drug advances in over a decade, Outcomes from the examine, offered on the annual assembly of the American Society for Scientific Oncology and will quickly set up a brand new first-line remedy for individuals with HER2-positive metastatic breast most cancers. In the meantime, researchers are combining RNA and AI to develop tailored vaccines to fight most cancers. For a deeper understanding of latest technological breakthroughs in medication, FRANCE 24’s François Picard welcomes Dr. Moez Benali (MD, PhD), Senior Medical Director at Fortrea. Dr Benali is a member of Fortrea’s world medical workforce and presently heads Oncologues Sans Frontières.
Source link
RNA Covid vaccine was initially 'developed for oncology use and was already in phase 2'
